TABLE 3.
Description of tuberculosis history and presentation amongst study participants.
Variable | n | % | CD4 cell count (cells/mm3) |
HIV viral load (copies/mL) |
||
---|---|---|---|---|---|---|
Median | IQR | Median | IQR | |||
Previous history of TB | 294 | 24.0 | 63 | 26–176 | 97 948 | 458–657 750 |
TB at current presentation | 244 | 19.9 | 109 | 37–296 | 1740 | 0–240 623 |
First episode of TB | 216 | 88.5 | 59 | 25–156 | 106 823 | 599–659 109 |
Recurrant episode of TB | 28 | 11.5 | 93 | 51–252 | 962 | 15–422 285 |
Single-organ TB | 174 | 71.3 | 82 | 34–226 | 25 000 | 248–398 515 |
Disseminated miliary TB | 38 | 15.6 | 37 | 22–87 | 361 172 | 7050–1 050 000 |
Disseminated non-miliary TB | 32 | 13.1 | 42 | 14–141 | 157 532 | 2050–1 163 090 |
Pulmonary TB† | 101 | 41.4 | 89 | 29–202 | 130 000 | 450–710 435 |
Extrapulmonary TB: | 143 | 58.6 | 68 | 25–154 | 920 468 | 288 550–2 334 203 |
Miliary TB | 38 | 15.6 | 37 | 22–87 | 361 172 | 7050–1 050 000 |
Pleural TB | 31 | 12.7 | 139 | 56–313 | 1510 | 0–69 250 |
Abdominal TB | 27 | 11.1 | 54 | 25–112 | 43 100 | 710–475 908 |
Tuberculous meningitis (TBM) | 23 | 9.4 | 104 | 35–220 | 141 190 | 231–264 500 |
Tuberculous lymphadenitis | 10 | 4.1 | 21 | 7–75 | 65 200 | 1980–184 000 |
Tuberculous pericarditis | 9 | 3.7 | 65 | 47–120 | 3500 | 819–35 963 |
Tuberculoma | 4 | 1.6 | 150 | 26–269 | 48 373 | 15–1 005 044 |
Urogenital TB | 3 | 1.2 | 76 | 39–183 | 210 064 | 129 459–805 032 |
Spinal TB | 2 | 0.8 | 525 | 512–537 | 2097 | 1918–2275 |
Tuberculous osteomyelitis | 1 | 0.4 | 15 | 15–15 | 531 001 | 531 001–531 001 |
Note: Probable cases of tuberculosis were also included as microbiological confirmation was not available for all cases.
TB, tuberculosis; IQR, interquartile range.
, Only includes participants with isolated pulmonary tuberculosis. The total number of pulmonary tuberculosis cases will be 171 (70.1%) if participants with both pulmonary and concurrent extrapulmonary tuberculosis are included.